People · Operator

D. Mark Dorman

Named in public records as an officer, director or promoter · active 2010–2020 · Healthtech, Other, Other Health Care

3
Companies
3
Filings
$64.5M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Equality Health, LLCHealthtechSeries C$45.0M$1.2B2016
Providien, Inc.OtherSeries A$10.5M$158.9M2010
Arizona Nutritional Supplements, LLCOther Health CareSeries A$9.0M$49.1M2020
Operator network

D. Mark Dorman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Hugh Lytle · 3 companies · 1 sharedHugh LytleJeffrey Butcher · 2 companies · 1 sharedJeffrey ButcherDavid L. Goldberg · 1 companies · 1 sharedDavid L. GoldbergCharles M. Stroupe · 1 companies · 1 sharedCharles M. StroupeJ. Dietz Fry · 1 companies · 1 sharedJ. Dietz FryJeffrey S. Goble · 1 companies · 1 sharedJeffrey S. GobleAaron Blunck · 1 companies · 1 sharedAaron BlunckBradaigh Wagner · 1 companies · 1 sharedBradaigh WagnerJonathan Pinkus · 1 companies · 1 sharedJonathan PinkusMike Beardall · 1 companies · 1 sharedMike BeardallMike Zawalski · 1 companies · 1 sharedMike ZawalskiEquality Health, LLC · $45.0M raisedEquality Health, LLCProvidien, Inc. · $10.5M raisedProvidien, Inc.Arizona Nutritional Supplements, LLC · $9.0M raisedArizona Nutritional S…D. Mark DormanDD
D. Mark Dorman Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside D. Mark Dorman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Hugh Lytle13
Jeffrey Butcher12
Mike Beardall11
Mike Zawalski11
Bradaigh Wagner11
Aaron Blunck11
David L. Goldberg11
J. Dietz Fry11
Jeffrey S. Goble11
Charles M. Stroupe11
Jonathan Pinkus11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.